DeutschNewstral
Article
Haaretz on 2019-01-07 20:57
Business in Brief: Teva Threatened With Strike at Main Plant for Making Top-selling Copaxone Drug
Related news
EU antitrust authorities launch probe of Teva over Copaxone drugtimesofisrael.com- Business in Brief: Teva in Talks to Sell Medical Equipment Manufacturer at $80 MillionHaaretz
Mylan surges, Teva slumps after FDA approves Copaxone copymetro.us- BTeva plunges after U.S. judge invalidates four Copaxone patentsbloomberg.com
EU antitrust regulators investigating Teva over its Copaxone drugThe Jerusalem Post (JPost.com)- MTeva shares rise as company offers reassurance on former flagship drug Copaxonemarketwatch.com
Allergan selling generics to TevaArkansas Online- Business in Brief: Teva Clears Way to Sell Medical-device UnitHaaretz
Histadrut calls strike over Teva cutsisraelnationalnews.com- Business in Brief: Teva Reaches $135m Settlement With Illinois Over Wholesale Drug PricesHaaretz
- Business in Brief: Teva Pushes Back Completion of Allergan Deal to JuneHaaretz
- Business in Brief: India’s Dr. Reddy’s to Buy Eight Generic Drugs From Teva and AllerganHaaretz
- Business in Brief: Teva Patent Dispute With Swiss Firm Reaches U.S. Supreme CourtHaaretz
- Business in Brief / Teva said to be eyeing Mexican drug makerHaaretz
- Teva steadiesisraelnationalnews.com
Israeli workers strike nationwide to protest Teva layoffsMerced Sun-Star- GTeva boosted as FDA delays generic Copaxoneglobes.co.il
- Business in Brief: Cofix Discount Cafe Chain to Expand Into Russia, Selling Coffee for 50 Rubles a CupHaaretz